Literature DB >> 3044713

Bone changes in alcoholic liver cirrhosis. A histomorphometrical analysis of 52 cases.

J A Jorge-Hernandez1, C E Gonzalez-Reimers, A Torres-Ramirez, F Santolaria-Fernandez, C Gonzalez-Garcia, J N Batista-Lopez, M Pestana-Pestana, L Hernandez-Nieto.   

Abstract

Bone biopsies of 52 histologically confirmed alcoholic cirrhotic patients and 15 age- and sex-matched controls have been histomorphometrically analyzed determining trabecular bone volume (TBV), mineralized bone volume (MBV), and osteoid volume (OV). We also determined serum PTH, 25-OH-D3, calcitonin, FSH, LH, estradiol, testosterone, T3 and T4, urine cortisol, routine liver function tests, serum and urinary calcium, phosphorus, and magnesium. We found a high prevalence of osteoporosis: TBV was significantly lower in cirrhotic patients (T = 7.23, P less than 0.001), 41 of them being in the range of osteoporosis; none of them had osteomalacia. Levels of all the above-mentioned hormones and electrolytes were almost normal, and no correlation was found between them and liver function tests, as occurred with the bone parameters.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044713     DOI: 10.1007/BF01535783

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Hepatic osteodystrophy.

Authors:  J E Compston; R P Thompson
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

Review 2.  Regulation of bone formation.

Authors:  L G Raisz; B E Kream
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

3.  The bones in chronic liver disease.

Authors:  C R Paterson; M S Losowsky
Journal:  Scand J Gastroenterol       Date:  1967       Impact factor: 2.423

Review 4.  Vitamin D metabolism and chronic liver disease.

Authors:  M R Wills; J Savory
Journal:  Ann Clin Lab Sci       Date:  1984 May-Jun       Impact factor: 1.256

5.  Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease.

Authors:  J B Dibble; P Sheridan; R Hampshire; G J Hardy; M S Losowsky
Journal:  Q J Med       Date:  1982

6.  Bone disease in primary biliary cirrhosis: increased bone resorption and turnover in the absence of osteoporosis or osteomalacia.

Authors:  J A Cuthbert; C Y Pak; J E Zerwekh; K D Glass; B Combes
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  [Vitamin D, parathormone, calcitonin and bone histomorphometry in patients with cirrhosis].

Authors:  B Patri; Y Le Charpentier; J Guéris; M C Calmettes; J Dubrisay
Journal:  Rev Rhum Mal Osteoartic       Date:  1978-11

8.  Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

Authors:  D S Matloff; M M Kaplan; R M Neer; M J Goldberg; W Bitman; H J Wolfe
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

9.  Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease.

Authors:  J B Dibble; P Sheridan; R Hampshire; G J Hardy; M S Losowsky
Journal:  Clin Endocrinol (Oxf)       Date:  1981-10       Impact factor: 3.478

10.  Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis.

Authors:  J E Compston; R P Thompson
Journal:  Lancet       Date:  1977-04-02       Impact factor: 79.321

View more
  7 in total

1.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

Review 2.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

3.  Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.

Authors:  G R Corazza; F Trevisani; M Di Stefano; S De Notariis; G Veneto; L Cecchetti; L Minguzzi; G Gasbarrini; M Bernardi
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Use of calcaneal ultrasound and biochemical markers to assess the density and metabolic state of the bones of adults with hepatic cirrhosis.

Authors:  Dorothy J VanderJagt; Edith Okeke; Christine Calvin; Carmen Troncoso; Michael Crossey; Robert H Glew
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

Review 5.  Diagnosis and Management of Cirrhosis-Related Osteoporosis.

Authors:  Lívia Alves Amaral Santos; Fernando Gomes Romeiro
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

6.  Bone microarchitecture and bone turnover in hepatic cirrhosis.

Authors:  R Wakolbinger; C Muschitz; G Scheriau; G Bodlaj; R Kocijan; X Feichtinger; J E Schanda; J Haschka; H Resch; P Pietschmann
Journal:  Osteoporos Int       Date:  2019-02-20       Impact factor: 4.507

7.  Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats.

Authors:  F A Pereira; R Mattar; I Facincani; H L A Defino; L N Z Ramalho; V Jorgetti; J B Volpon; F J A de Paula
Journal:  Braz J Med Biol Res       Date:  2012-09-11       Impact factor: 2.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.